共 50 条
- [21] ENHANCED TRANSCRIPTION OF P-GLYCOPROTEIN GENE IN ADRIAMYCIN-RESISTANT P388 LEUKEMIA-CELLS CLINICAL AND INVESTIGATIVE MEDICINE-MEDECINE CLINIQUE ET EXPERIMENTALE, 1987, 10 (04): : B112 - B112
- [23] INVIVO CHARACTERISTICS OF RESISTANCE AND CROSS-RESISTANCE OF AN ADRIAMYCIN-RESISTANT SUBLINE OF P388 LEUKEMIA CANCER TREATMENT REPORTS, 1978, 62 (10): : 1535 - 1547
- [24] THERAPEUTIC SYNERGISM (TS) OF HOMOHARRINGTONINE (H) PLUS 5-FLUOROURACIL (FU) AGAINST LEUKEMIA P388 (P388/0) AND ARA-C-RESISTANT P388 (P388/ARA-C) PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1982, 23 (MAR): : 199 - 199
- [25] RESTORATION OF DRUG SENSITIVITY BY NITROXAZEPINE HYDROCHLORIDE IN P388 MURINE LEUKEMIA-CELLS RESISTANT TO ADRIAMYCIN CANCER DRUG DELIVERY, 1987, 4 (01): : 1 - 9
- [28] CULTURED LEUKEMIA P388 CELLS RESISTANT TO VINCRISTINE (P388 VCR) OR TO ADRIAMYCIN (P388 ADR) - CROSS-RESISTANCE TO PUROMYCIN (NSC-3055), ACTINOMYCIN-D (NSC-3053), COLCHICINE (NSC-757), AND VINBLASTINE (NSC-49842) PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 334 - 334
- [29] EVALUATION OF NEW ANTHRACYCLINES ON P388-LEUKEMIA SENSITIVE (P388/S) OR RESISTANT (P388/R) TO DOXORUBICIN (DX) PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1983, 24 (MAR): : 280 - 280